Immunize.org

The ImmunizeOrg website offers a wealth of resources to support your vaccination practice. You’ll find “Notification of Immunization Letter Template” here: https://lnkd.in/e7f5Ujk7. This 1-page PDF document (last updated January 2025) is free to download, print, and share. #ImmunizeOrg #savelivesimmunize #vaccinessavelives #vaccinate

Today’s Ask the Experts question and answer is presented by ImmunizeOrg’s president and CEO, Dr. Kelly L. Moore. Established more than 25 years ago, our popular Ask the Experts feature offers answers to more than a thousand questions about vaccines and their administration. We regularly add new questions and answers to this feature, and review and revise all information to reflect current ACIP recommendations.       Find today’s video here: https://lnkd.in/eHDcUBNn    To find the full set of Immunize.org's Ask the Experts RSV Vaccine Q&As, visit: https://lnkd.in/e29KatW4    #ImmunizeOrg #vaccinessavelives #savelivesimmunize #vaccination #vaccineswork 

We love hearing from the healthcare and public health professionals we serve about how they use the news and resources we provide. Everyone who recommends or administers vaccines is welcome to visit our website and subscribe to our free weekly newsletter, IZ Express. We are here to provide the trusted, timely information you need to support the delivery of safe and effective immunization services for people of all ages. Visit us at www.immunize.org Join 53,000+ subscribers to our free weekly IZ Express newsletter at: https://lnkd.in/ehamh7Sb. #ImmunizeOrg #subscribe #publichealth #vaccinessavelives #vaccinate #healthcare

In June 2021, ACIP voted to recommend Dengvaxia for routine use in children age 9 through 16 years with laboratory-confirmed previous dengue virus infection and living in areas where CDC has classified dengue as endemic. The recommendation is only for persons with confirmed previous DENV infection because Dengvaxia is associated with an increased risk for severe dengue in those who experience their first natural infection (i.e., primary infection) after vaccination. The vaccine is not approved for use in U.S. travelers who are visiting but not living in an area where dengue is common. The most current ACIP recommendations for Dengvaxia are available at https://lnkd.in/ex89j2wK. CDC has developed a pre-vaccination checklist for evaluating whether a child should receive Dengvaxia: https://lnkd.in/eCrk9p6M. You’ll find this answer, as well as other dengue vaccine Q&As, here: https://lnkd.in/gGtX6SHq. #ImmunizeOrg #savelivesimmunize #vaccinessavelives #vaccinate #dengue

The ImmunizeOrg website offers a wealth of resources to support your vaccination practice. You’ll find “Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools” here: https://lnkd.in/eXdcXtNy. This 3-page PDF (last updated January 2025) is free to download, print, and share. #ImmunizeOrg #savelivesimmunize #vaccinessavelives #vaccinate #covid

Anxiety about needles is common in children and adults. For some, anxiety can lead them to delay or avoid vaccination, even if they know it’s important. ImmunizeOrg’s president and CEO, Dr. Kelly L. Moore offers practical advice for healthcare professionals and the public in the Improving the Vaccination Experience Video Series. Each video is about 4 minutes long.     Find today’s video here: https://lnkd.in/gVJK3d66    To find the full set of ImmunizeOrg's Improving the Vaccination Experience Video Series, visit our YouTube channel at: https://lnkd.in/eZja8QhT.      #ImmunizeOrg #vaccinessavelives #savelivesimmunize  

Get the immunization news you need in this week’s issue of IZ Express. More Top Stories include: • Updated 65+ Flu Defense website offers resources for healthcare professionals serving older adults • Influenza activity is high in most states; vaccination is best way to prevent influenza Read the entire issue online: https://lnkd.in/eyiJWXZK 55,000+ healthcare professionals rely on IZ Express to keep up to date on new and updated vaccine recommendations from CDC, notable publications, and vaccination resources from Immunize.org and our partners. Subscribe for free today: www.immunize.org/subscribe #savelivesimmunize #immunizeorg

Dengvaxia (Sanofi) is a live-attenuated, chimeric tetravalent dengue vaccine built on a yellow fever 17D backbone. It is designed to protect against all four DENV serotypes. It was licensed by the FDA in May 2019 for children and adolescents age 9 through 16 years with a confirmed history of previous dengue infection. FDA lowered the youngest age for licensed use from 9 years to 6 years in 2023; however, CDC’s recommendations to begin routine vaccination of children with serologic evidence of prior dengue infection at age 9 years remains unchanged. The recommendation for vaccination is restricted to people age 9 through 16 years with confirmed previous DENV infection because Dengvaxia is associated with an increased risk for severe dengue in those who experience their first natural infection (i.e., primary infection) after vaccination. In 2024, Sanofi announced plans to discontinue production of Dengvaxia in the third quarter of 2026 due to low global demand. Other dengue vaccines are in late stages of development; however, there are no other licensed dengue vaccines available in the United States. You’ll find this answer, as well as other dengue vaccine Q&As, here: https://lnkd.in/gGtX6SHq. #ImmunizeOrg #savelivesimmunize #vaccinessavelives #vaccinate #dengue

Register for an Immunize.org Website Office Hours Zoom session to learn tips and tricks for navigating the Immunize.org website and get your website questions answered. Each 45-minute session opens with a short, live demonstration on our popular “Official Guidance” website section. You will be able to ask your questions live or submit them when you register for the session. Register now for the next Immunize.org Website Office Hours Zoom session. Registration for Wednesday, February 12 at 4:00 p.m. ET: https://bit.ly/42GUM3c Registration for Thursday, February 13 at 12:00 p.m. ET: https://bit.ly/4gjF80Q #savelivesimmunize #immunizeorg

The ImmunizeOrg website offers a wealth of resources to support your vaccination practice. You’ll find “Standing orders for administering hepatitis B vaccine to children and teens” here: https://lnkd.in/et7p_bVu. This 2-page PDF document (last updated January 2025) is free to download, print, and share. #ImmunizeOrg #savelivesimmunize #vaccinessavelives #vaccinate #hepatitis